Saurabh Chhabra, MD, Oncology, Milwaukee, WI, Froedtert and the Medical College of Wisconsin Froedtert Hospital

SaurabhChhabraMD

Oncology Milwaukee, WI

Hematologic Oncology

Assistant Professor of Medicine, Medical College of Wisconsin, Milwaukee, WI

Dr. Chhabra is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Chhabra's full profile

Already have an account?

Education & Training

  • Stanford University
    Stanford UniversityFELLOWSHIP
  • UMDNJ-Robert Wood Johnson Medical School
    UMDNJ-Robert Wood Johnson Medical SchoolFELLOWSHIP
  • UMDNJ-Robert Wood Johnson Medical School
    UMDNJ-Robert Wood Johnson Medical SchoolRESIDENCY
  • Mount Sinai School of Medicine
    Mount Sinai School of MedicineINTERNSHIP
  • Delhi University College of Medical Sciences
    Delhi University College of Medical SciencesMEDICAL_SCHOOL

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 2016 - 2021
  • SC State Medical License
    SC State Medical License 2012 - 2021
  • CA State Medical License
    CA State Medical License 2011 - 2022
  • NJ State Medical License
    NJ State Medical License 2008 - 2011
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Population-Level Trends in Early Mortality and Overall Survival of Patients with Multiple Myeloma. Are We Facing Stagnation?
    Saurabh Chhabra, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Overall Survival of Triple Class Refractory, Penta-Exposed Multiple Myeloma (MM) Patients Treated with Selinexor Plus Dexamethasone or Conventional Care: A Combined An...
    Saurabh Chhabra, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Equate, a Phase 1b/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of a Novel Targeted Anti-CD6 Therapy, Itolizu...
    Saurabh Chhabra, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Subsequent Treatment Outcomes of Multiple Myeloma Refractory to CD38-Monoclonal Antibody Therapy 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Adjuvant Doxycycline to Enhance Anti-Amyloid Effects: Results from the DUAL (Doxycycline to Upgrade response in AL amyloidosis) Study 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Phase I/II Trial of Bendamustine, Ixazomib and Dexamethasone (BID) in Patients (pts.) with Relapsed/Refractory Multiple Myeloma (RRMM) 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Weighing Conditioning Regimens for Patients with CML Undergoing Transplant
    Weighing Conditioning Regimens for Patients with CML Undergoing TransplantJanuary 01, 2019

Professional Memberships

  • American Society of Hematology
    Member
  • American Society of Blood and Marrow Transplantation
    Member

Other Languages

  • Hindi, Urdu

Hospital Affiliations